Market Overview:
The global point of care diagnostic and testing market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of chronic diseases, rising demand for rapid diagnosis, and technological advancements in point-of-care diagnostics. The global point-of-care diagnostics market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into devices, consumables, and others. The devices segment is further subsegmented into instruments and consumables. The instruments subsegment includes analyzers/testing equipment such as blood gas analyzers; coagulation analyzers; hematology analyzers; immunoassay systems; clinical chemistry systems; urine analysis systems; molecular diagnostics platforms (PCRs); other types of analytical instruments). The consumables subsegment includes test strips/cartridges for glucose meters & cholesterol meters; lancets & needles for blood sampling devices (finger prick test); pipettes & tips for sample handling etc.). On the basis of application, the market is divided into hospitals、clinics、home users、and others (laboratories).
Product Definition:
Point of care diagnostic and testing is a type of medical testing that is performed in a healthcare setting, such as a hospital or clinic, rather than in a laboratory. This type of testing can provide doctors with rapid results that can help them to make decisions about how to treat patients. Point of care diagnostic and testing can be used to diagnose conditions, monitor the progress of treatments, and screen for diseases.
Device:
The global device is expected to grow at a CAGR of XX% during the forecast period. The major factor attributing to its growth includes rising geriatric population base, increasing prevalence of chronic diseases and rapid technological advancements in healthcare sector. Moreover, growing demand for home care settings coupled with cost-effectiveness associated with point-of-care (POC) testing is also anticipated to drive the market growth during the forecast period.
Consumables:
Consumables are the instruments, kits, and reagents that are used in diagnostic procedures. They include products such as test tubes, slides and coverslips, beakers or containers of various sizes for mixing solutions or chemicals; pipettes (for dispensing small quantities of liquid), mortars and pestles; cotton swabs; applicators (for applying drops); thermometers (inclined head type for oral cavity); balances or scales; stop watches or timing devices.
Application Insights:
Based on application, the global point of care diagnostic and testing market is segmented into hospitals, clinics, home healthcare settings and others. Hospitals held the largest share in 2017 due to high usage of point of care diagnostics in hospital-based laboratories. The growing prevalence of chronic diseases such as cancer and cardiovascular diseases has led to an increase in demand for rapid diagnosis that can be performed with point of care devices. This is anticipated to drive growth over the forecast period.
Clinics are expected to witness significant growth during the forecast period owing to increasing demand for faster turnaround time along with improved patient satisfaction by providing accurate results at a cheaper cost comparedto traditional lab methods used across clinics worldwide.
Regional Analysis:
North America dominated the global point of care diagnostic and testing market in 2017. This can be attributed to various factors such as favorable reimbursement policies, presence of key players, and increasing government funding for research & development activities. For instance, in 2015 – 2016 academic year, researchers from U.S received around USD X million in funding from the National Institutes of Health (NIH) for diagnostics-related projects.
Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to rising healthcare expenditure by governments and private sectors along with increasing patient awareness levels pertaining to early diagnosis of diseases.
Growth Factors:
- Increasing incidence of lifestyle diseases such as diabetes and heart diseases
- Rising geriatric population
- Growing demand for personalized medicine
- Technological advancements in Point of Care Diagnostic and Testing market
- Increasing public-private investments in healthcare sector
Scope Of The Report
Report Attributes
Report Details
Report Title
Point of Care Diagnostic and Testing Market Research Report
By Type
Device, Consumables, Others
By Application
Hospitals, Clinics, Home, Others
By Companies
F. Hoffmann-La Roche, Qiagen, Danaher, Becton Dickinson and Company, Biomerieux, Siemens Healthcare, Zoetis, Abbott, Bayer, Johnson and Johnson, Nova Biomedical, Trividia Health, Quidel Corporation, Trinity Biotech, Sekisui Diagnostics, Orasure Technologies, Nipro, Spectral Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
179
Number of Tables & Figures
126
Customization Available
Yes, the report can be customized as per your need.
Global Point of Care Diagnostic and Testing Market Report Segments:
The global Point of Care Diagnostic and Testing market is segmented on the basis of:
Types
Device, Consumables, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Home, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- F. Hoffmann-La Roche
- Qiagen
- Danaher
- Becton Dickinson and Company
- Biomerieux
- Siemens Healthcare
- Zoetis
- Abbott
- Bayer
- Johnson and Johnson
- Nova Biomedical
- Trividia Health
- Quidel Corporation
- Trinity Biotech
- Sekisui Diagnostics
- Orasure Technologies
- Nipro
- Spectral Medical
Highlights of The Point of Care Diagnostic and Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Device
- Consumables
- Others
- By Application:
- Hospitals
- Clinics
- Home
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Point of Care Diagnostic and Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Point of care diagnostic and testing is a term used to describe the practice of providing medical care in an outpatient setting, such as a doctor's office or clinic. This type of service can include tests that are not typically done in a hospital or other clinical setting.
Some of the major companies in the point of care diagnostic and testing market are F. Hoffmann-La Roche, Qiagen, Danaher, Becton Dickinson and Company, Biomerieux, Siemens Healthcare, Zoetis, Abbott, Bayer, Johnson and Johnson, Nova Biomedical, Trividia Health, Quidel Corporation, Trinity Biotech, Sekisui Diagnostics, Orasure Technologies, Nipro, Spectral Medical.
The point of care diagnostic and testing market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Point of Care Diagnostic and Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Point of Care Diagnostic and Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Point of Care Diagnostic and Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Point of Care Diagnostic and Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Point of Care Diagnostic and Testing Market Size & Forecast, 2018-2028
4.5.1 Point of Care Diagnostic and Testing Market Size and Y-o-Y Growth
4.5.2 Point of Care Diagnostic and Testing Market Absolute $ Opportunity
Chapter 5 Global Point of Care Diagnostic and Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Point of Care Diagnostic and Testing Market Size Forecast by Type
5.2.1 Device
5.2.2 Consumables
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Point of Care Diagnostic and Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Point of Care Diagnostic and Testing Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Home
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Point of Care Diagnostic and Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Point of Care Diagnostic and Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Point of Care Diagnostic and Testing Analysis and Forecast
9.1 Introduction
9.2 North America Point of Care Diagnostic and Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Point of Care Diagnostic and Testing Market Size Forecast by Type
9.6.1 Device
9.6.2 Consumables
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Point of Care Diagnostic and Testing Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Home
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Point of Care Diagnostic and Testing Analysis and Forecast
10.1 Introduction
10.2 Europe Point of Care Diagnostic and Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Point of Care Diagnostic and Testing Market Size Forecast by Type
10.6.1 Device
10.6.2 Consumables
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Point of Care Diagnostic and Testing Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Home
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Point of Care Diagnostic and Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Point of Care Diagnostic and Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Point of Care Diagnostic and Testing Market Size Forecast by Type
11.6.1 Device
11.6.2 Consumables
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Point of Care Diagnostic and Testing Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Home
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Point of Care Diagnostic and Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America Point of Care Diagnostic and Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Point of Care Diagnostic and Testing Market Size Forecast by Type
12.6.1 Device
12.6.2 Consumables
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Point of Care Diagnostic and Testing Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Home
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Point of Care Diagnostic and Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Point of Care Diagnostic and Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Point of Care Diagnostic and Testing Market Size Forecast by Type
13.6.1 Device
13.6.2 Consumables
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Point of Care Diagnostic and Testing Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Home
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Point of Care Diagnostic and Testing Market: Competitive Dashboard
14.2 Global Point of Care Diagnostic and Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 F. Hoffmann-La Roche
14.3.2 Qiagen
14.3.3 Danaher
14.3.4 Becton Dickinson and Company
14.3.5 Biomerieux
14.3.6 Siemens Healthcare
14.3.7 Zoetis
14.3.8 Abbott
14.3.9 Bayer
14.3.10 Johnson and Johnson
14.3.11 Nova Biomedical
14.3.12 Trividia Health
14.3.13 Quidel Corporation
14.3.14 Trinity Biotech
14.3.15 Sekisui Diagnostics
14.3.16 Orasure Technologies
14.3.17 Nipro
14.3.18 Spectral Medical
